In vivo tumor gene delivery using novel peptideticles: pH-responsive and ligand targeted core–shell nanoassembly

31Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Modulating cancer causing genes with nucleic acid based-molecules as cutting-edge approaches need efficient delivery systems to succeed in clinic. Herein, we report design and fabrication of a novel tissue penetrating peptideticle with charge-structure switching in tumor microenvironment for an effective gene delivery. The comparative in vitro studies indicate that peptideticles identify and bind to tumor endothelial cells and efficiently penetrate into multicellular tumor spheroid. In addition, negatively charged peptideticle at pH 7.4, prevent unwanted interaction while its sharp charge-structure switching at pH 6.2–6.9 (e.g. in tumor tissue) facilitates malignant cells penetration. More importantly, upon systemic administration into tumor bearing mice, peptideticles effectively localized in tumor tissue and delivered luciferase gene with a 200-fold higher efficiency compared to their non-pH-responsive counterparts. In conclusion, this study presents a robust nanoassembly of safe materials for high efficient tumor gene delivery.

Cite

CITATION STYLE

APA

Alipour, M., Majidi, A., Molaabasi, F., Sheikhnejad, R., & Hosseinkhani, S. (2018). In vivo tumor gene delivery using novel peptideticles: pH-responsive and ligand targeted core–shell nanoassembly. International Journal of Cancer, 143(8), 2017–2028. https://doi.org/10.1002/ijc.31577

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free